NCT00448903View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

PHASE3CompletedINTERVENTIONAL

Enrollment

329

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

April 30, 2010

Conditions

Foot Ulcer, Diabetic

Interventions

DRUG

Bemiparin

Bemiparin sodium

DRUG

Placebo

Sodium Chloride 0,9%

Trial Locations (6)

Unknown

CROATIA, Zagreb

POLAND, Warsaw

ROMANIA, Timișoara

RUSSIA, Saint Petersburg

SERBIA, Belgrade

SPAIN, Madrid

All Listed Sponsors

lead

Rovi Pharmaceuticals Laboratories

INDUSTRY

NCT00448903 - Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter